We recently published a list of the 11 Most Promising Small-Cap Stocks According to Analysts. In this article, we are going ...

New research reveals how chemokines and G protein-coupled receptors selectively bind each other to control how cells move.

Tectonic Therapeutic, Inc.’s TECX share price has dipped by 7.37%, which has investors questioning if this is right time to ...

In regenerative science, B7-33's potential to influence fibroblast activity and collagen turnover suggests possible implications for tissue repair and wound healing. Given that fibrosis is often a ...

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, ...

Scientists from St. Jude Children's Research Hospital and the Medical College of Wisconsin have created a data science framework to better understand how cells travel through the body.

Scientists from St. Jude Children's Research Hospital and the Medical College of Wisconsin have created a data science ...

April 23, 2025). Scientists from St. Jude Children's Research Hospital and the Medical College of Wisconsin have created a data ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

G protein-coupled receptors (GPCRs) are involved in many diseases, yet raising therapeutic antibodies against them is notoriously difficult because the transmembrane receptors contain only short ...

Both Structure (NASDAQ:GPCR) and Metsera (NASDAQ:MTSR) own oral GLP-1 receptor agonists which are currently undergoing mid-stage trials for patients with obesity and overweight with or without ...

Structure Therapeutics (GPCR) stock and Metsera (MTSR) stock soar as Eli Lilly (LLY) reports promising Phase 3 results for ...